Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia.
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 1, p. 91
- By:
- Publication type:
- Article
Works matching IS 00485764 AND DT 2022 AND VI 52 AND IP 1
Results: 7
1
2
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 1, p. 68
- By:
- Publication type:
- Article
3
Antipsychotic-Induced Laryngeal Dystonia.
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 1, p. 61
- By:
- Publication type:
- Article
4
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains.
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 1, p. 57
- By:
- Publication type:
- Article
5
A Case Report of Stuttering Induced by Risperidone and Chlorpromazine.
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 1, p. 53
- By:
- Publication type:
- Article
6
Inflammatory Biomarker and Response to Antidepressant in Major Depressive Disorder: a Systematic Review and Meta-Analysis.
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 1, p. 36
- By:
- Publication type:
- Article
7
Protein Biomarkers in Monocytes and CD4<sup>+</sup> Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal-Amplified Flow Cytometry.
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 1, p. 8
- By:
- Publication type:
- Article